Braveheart Bio, Inc. (BRVE)
17.28
-0.14
(-0.78%)
USD |
NASDAQ |
Nov 06, 10:24
Braveheart Bio EPS Diluted (Quarterly) : -0.2066 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2066 |
| March 31, 2026 | -0.1586 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.0042 |
| March 31, 2025 | -0.0011 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 1.053 |
| Trulieve Cannabis Corp. | -2.107 |
| Journey Medical Corp. | -0.0114 |
| Turn Therapeutics, Inc. | -0.1964 |
| ANI Pharmaceuticals, Inc. | 1.052 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.99M |
| Total Expenses (Quarterly) | 14.99M |
| Enterprise Value | 1.659B |
| Earnings Yield | -2.14% |
| Normalized Earnings Yield | -2.135 |